CRE Information Request to DEA.

Visit the Kratom Roundtable


The timely and positive response from the DEA

2nd CRE  Letter to the DEA  (September 12, 2016)



1sr CRE Letter to the DEA    (September 8, 2016)



CRE has submitted a Request for Information to DEA regarding its listing of kratom as a Schedule I narcotic. The information so requested is the DEA letter to HHS as mentioned in the Federal Register which announced the aforementioned listing, which states:

The Administrator [DEA} transmitted notice of his intent to place mitragynine and 7-hydroxymitragynine in schedule I on a temporary basis to the Assistant Secretary[HHS] by letter dated May 6, 2016.

Commentaries on OIRA’s Actions to Install Discipline into the Regulatory Process

Lash Review 

Revesz Livermore

Source Watch

Miller(Manuscript;Part 5, pg. 45)-Tozzi Enforcement Axis


DOD Analysts Fired By An Act of Congress (document  pg. 164)